Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eukedos SpAMIL:EUK +1.96%32 EV-to-EBITDA is 12.51 as of Aug. 30, 2026, which is 6% above its 10-year median of 11.81. GuruFocus rates MIL:EUK with a GF Score™ of 32/100 and a GF Value™ of €0.89 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 515 Healthcare Providers & Services companies, Eukedos SpA ranks worse than 57.28% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Eukedos SpA's enterprise value is €140.67 Mil.
Eukedos SpA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €11.24 Mil. Therefore, Eukedos SpA's EV-to-EBITDA for today is 12.51.
The historical rank and industry rank for Eukedos SpA's EV-to-EBITDA or its related term are showing as below:
MIL:EUK'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.88 Med: 11.81 Max: 51.02
Current: 12.51
During the past 13 years, the highest EV-to-EBITDA of Eukedos SpA was 51.02. The lowest was 6.88. And the median was 11.81.
MIL:EUK's EV-to-EBITDA is ranked worse than 57.28% of 515
companies
in the Healthcare Providers & Services industry
Industry Median: 10.62
vs MIL:EUK: 12.51
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Eukedos SpA's PE Ratio (TTM) for today is calculated as:
Eukedos SpA's share price for today is €0.52.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eukedos SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.032.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Eukedos SpA's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Eukedos SpA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eukedos SpA EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Eukedos SpA's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Eukedos SpA's EV-to-EBITDA falls into.
Eukedos SpA's current Enterprise Value is €140.67 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eukedos SpA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €11.24 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eukedos SpA (MIL:EUK) has a EV-to-EBITDA of 12.51 as of Aug. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Eukedos SpA. This is near median its historical median of 11.81. Over the past decade, Eukedos SpA's EV-to-EBITDA has ranged from 6.88 to 51.02. According to the industry distribution chart, Eukedos SpA ranks #295 out of 515 companies in the Healthcare Providers & Services industry, placing it in the top 57.3%.
Is Eukedos SpA's EV-to-EBITDA too high?
Eukedos SpA's current EV-to-EBITDA of 12.51 is near median its 10-year median of 11.81. Over the past 10 years, this metric has ranged from a low of 6.88 to a high of 51.02. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.62. Eukedos SpA's value of 12.51 is 17.8% above this industry median. Based on the distribution chart, Eukedos SpA ranks #295 out of 515 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Eukedos SpA has a GF Score™ of 32/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Eukedos SpA's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Eukedos SpA ranks #295 out of 515 companies for EV-to-EBITDA. This places Eukedos SpA in the lower half of its industry. The industry median EV-to-EBITDA is 10.62. Eukedos SpA's value of 12.51 is 17.8% above this benchmark. Historically, Eukedos SpA's own EV-to-EBITDA has ranged from 6.88 to 51.02 over the past decade. While the company's 10-year median is 11.81 vs. the industry median of 10.62, Eukedos SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.62, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eukedos SpA's current EV-to-EBITDA of 12.51 is 17.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Eukedos SpA. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eukedos SpA's current EV-to-EBITDA is 12.51, which is near median its own 10-year median of 11.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eukedos SpA stock overvalued right now?
Based on GuruFocus' analysis, Eukedos SpA (MIL:EUK) is currently considered Possible Value Trap. The stock's GF Value™ is €0.89, compared to a current price of €0.52 — trading 41.6% below its estimated fair value. The current EV-to-EBITDA is 12.51, which is near median its 10-year median of 11.81 and 17.8% above the Healthcare Providers & Services industry median of 10.62. Eukedos SpA's overall GF Score™ is 32/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Eukedos SpA (MIL:EUK), the current EV-to-EBITDA is 12.51 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eukedos SpA (MIL:EUK) Overvalued in 2026?
Based on GuruFocus' analysis, Eukedos SpA stock appears to be undervalued.
The current stock price of €0.52 is trading 41.6% below its estimated GF Value™ of €0.89.
GuruFocus considers Eukedos SpA to be Possible Value Trap.
Key valuation signals for MIL:EUK:
EV-to-EBITDA: 12.51 (near median its 10-year median of 11.81)
GF Value™: €0.89 vs. price of €0.52 (41.6% below fair value)
Industry Position: 17.8% above the Healthcare Providers & Services median (#295 of 515)
No single metric tells the full story. See the MIL:EUK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:EUK has been successfully added to your 
